Global Urinary Incontinence Treatment Devices
At cognitive, a dedicated team has worked on this report, we have disclosed one of the team member involved in the publication and client consultation process for your reference. You can initiate the discussion her via Book an appointment
At cognitive, our research analyst works closely with Urinary Incontinence Treatment Devices market experts to validate the gathered data and have the expert's opinion available for our clients. You can book a consultation call with our research analyst and industry experts on board (Subject to time availability and paid consultation services)
The base year for the analysis is 2025. Historical data has been considered for the period from 2022 to 2025. The year 2026 is considered as the estimated base for forecasting, with projections covering the period from 2026 to 2034. When we deliver the report that time we updated report data till the purchase date.
From the database of Cognitive, this is an unique identification number of reports and it will also have different reports associated with it.
Report edition's total number of pages for pdf format (Approximate)
Rating and review received by the reader or subscriber of the said report.
Athenaeum Visualization Dashboard: Access your purchased data/Report/Service through a sophisticated, interactive interface. The Athenaeum Dashboard allows you to preview data/reports and store them in a customizable dashboard, enabling you to filter metrics and uncover deeper trends specific to your enterprise needs.
PDF Access: To ensure the highest level of data integrity and confidentiality, your premium report editions are delivered as password-protected PDF files. These are securely shared via email and remain accessible within your dedicated Athenaeum account for future reference.
Versatile Multi-Format Export (Excel & MS Word): We provide the flexibility to integrate our research directly into your internal workflows. Upon request, relevant quantitative data and qualitative insights from your purchased reports can be provided in fully editable Microsoft Excel and Word formats.
Multiple Cloud Accounts: Benefit from a dedicated, encrypted cloud account that ensures your market intelligence is available on-demand. Access your research from any device, at any time, and from any location. Multiple Accounts facilitating seamless collaboration across your collegue or whole organization.
Athenaeum AI Assistant(Value-Added Service): Elevate your research capabilities with Athenaeum AI Assistant, our proprietary 24/7 research assistant. Equivalent in depth to a dedicated research analyst, this AI-driven tool provides round-the-clock data support and instant insights to help you navigate complex market landscapes in real-time.
As Cognitive a market research and consulting firm, we can provide Urinary Incontinence Treatment Devices market Analysis and consultation services with the help of our data collection processes and Proprietary research methodology called Full Truth. We have in-house team of research analysts and network of industry experts on board. In fact, we provided high-impact consualtion services to the listed client in competitior analysis. As an extension of our bespoke consulting engagements, we also provide access to Proprietary datasets of market analysis publish, making authoritative industry intelligence accessible to the public domain.
Proprietary Database, Market Surveys, Strategic Consultation & Advisory Services, Industry & Competitive Intelligence. along with Report Access and Athenaeum Dashboard Subscription — Revenue, Volume, Production, Trade Analysis, value chain and supply chain analysis, Market Size, Share, Forecast, Drivers, Trends, Growth Opportunities, ESG and more.
| Data Timeline | Historical Data: 2022-2025 | Base Year: 2025 | Forecast Period: 2026-2034 |
|---|---|
| Product Outlook: Segment Analysis | Urethral Slings, Electrical Stimulation Devices, Artificial Urinary Sphincters, Catheters |
| Incontinence Type Outlook: Segment Analysis | Stress Urinary Incontinence, Urge Urinary Incontinence, Mixed Incontinence, Overflow Incontinence |
| End-user Outlook: Segment Analysis | Hospitals, Ambulatory Surgery Centers, Clinics, Home Use |
|---|---|
| Regions & Countries Analysis |
|
Share your contact details to receive free updated sample copy/pages of the recently published edition of Urinary Incontinence Treatment Devices Market Report 2025.
According to Cognitive Market Research, the global Urinary Incontinence Treatment Devices market size will be USD 3780 million in 2025. It will expand at a compound annual growth rate (CAGR) of 8.90% from 2025 to 2033.
Market Drivers:
|
Market Restrains:
|
Market Trends:
|
| Market Size | 2021 (A) | 2025 (A) | 2033 (P) | CAGR |
|---|---|---|---|---|
| Global Urinary Incontinence Treatment Devices Market Sales Revenue | xxxx | $ 3780 Million | $ 7476.7 Million | 8.9% |
| North America Urinary Incontinence Treatment Devices Market Sales Revenue | xxxx | $ 1398.6 Million | $ 2467.3 Million | 7.4% |
| United States Urinary Incontinence Treatment Devices Market Sales Revenue | xxxx | $ 1103.5 Million | xxxx | 7.2% |
| Canada Urinary Incontinence Treatment Devices Market Sales Revenue | xxxx | $ 167.83 Million | xxxx | 8.2% |
| Mexico Urinary Incontinence Treatment Devices Market Sales Revenue | xxxx | $ 127.27 Million | xxxx | 7.9% |
| Europe Urinary Incontinence Treatment Devices Market Sales Revenue | xxxx | $ 1096.2 Million | $ 2018.7 Million | 7.9% |
| United Kingdom Urinary Incontinence Treatment Devices Market Sales Revenue | xxxx | $ 184.16 Million | xxxx | 8.7% |
| France Urinary Incontinence Treatment Devices Market Sales Revenue | xxxx | $ 100.85 Million | xxxx | 7.1% |
| Germany Urinary Incontinence Treatment Devices Market Sales Revenue | xxxx | $ 217.05 Million | xxxx | 8.1% |
| Italy Urinary Incontinence Treatment Devices Market Sales Revenue | xxxx | $ 94.27 Million | xxxx | 7.3% |
| Russia Urinary Incontinence Treatment Devices Market Sales Revenue | xxxx | $ 169.91 Million | xxxx | 6.9% |
| Spain Urinary Incontinence Treatment Devices Market Sales Revenue | xxxx | $ 89.89 Million | xxxx | 7% |
| Sweden Urinary Incontinence Treatment Devices Market Sales Revenue | xxxx | $ 33.98 Million | xxxx | 8% |
| Denmark Urinary Incontinence Treatment Devices Market Sales Revenue | xxxx | $ 23.02 Million | xxxx | 7.7% |
| Switzerland Urinary Incontinence Treatment Devices Market Sales Revenue | xxxx | $ 16.44 Million | xxxx | 7.6% |
| Luxembourg Urinary Incontinence Treatment Devices Market Sales Revenue | xxxx | $ 13.15 Million | xxxx | 8.2% |
| Rest of Europe Urinary Incontinence Treatment Devices Market Sales Revenue | xxxx | $ 153.47 Million | xxxx | 6.6% |
| Asia Pacific Urinary Incontinence Treatment Devices Market Sales Revenue | xxxx | $ 907.2 Million | $ 2194.4 Million | 11.7% |
| China Urinary Incontinence Treatment Devices Market Sales Revenue | xxxx | $ 381.02 Million | xxxx | 11.2% |
| Japan Urinary Incontinence Treatment Devices Market Sales Revenue | xxxx | $ 125.19 Million | xxxx | 10.2% |
| South Korea Urinary Incontinence Treatment Devices Market Sales Revenue | xxxx | $ 108.86 Million | xxxx | 10.8% |
| India Urinary Incontinence Treatment Devices Market Sales Revenue | xxxx | $ 90.72 Million | xxxx | 13.6% |
| Australia Urinary Incontinence Treatment Devices Market Sales Revenue | xxxx | $ 47.17 Million | xxxx | 11% |
| Singapore Urinary Incontinence Treatment Devices Market Sales Revenue | xxxx | $ 18.14 Million | xxxx | 12% |
| Taiwan Urinary Incontinence Treatment Devices Market Sales Revenue | xxxx | $ 35.38 Million | xxxx | 11.5% |
| South East Asia Urinary Incontinence Treatment Devices Market Sales Revenue | xxxx | $ 59.88 Million | xxxx | 12.5% |
| Rest of APAC Urinary Incontinence Treatment Devices Market Sales Revenue | xxxx | $ 40.82 Million | xxxx | 11.5% |
| South America Urinary Incontinence Treatment Devices Market Sales Revenue | xxxx | $ 143.64 Million | $ 299.1 Million | 9.6% |
| Brazil Urinary Incontinence Treatment Devices Market Sales Revenue | xxxx | $ 61.48 Million | xxxx | 10.2% |
| Argentina Urinary Incontinence Treatment Devices Market Sales Revenue | xxxx | $ 24.13 Million | xxxx | 10.5% |
| Colombia Urinary Incontinence Treatment Devices Market Sales Revenue | xxxx | $ 12.78 Million | xxxx | 9.4% |
| Peru Urinary Incontinence Treatment Devices Market Sales Revenue | xxxx | $ 11.78 Million | xxxx | 9.8% |
| Chile Urinary Incontinence Treatment Devices Market Sales Revenue | xxxx | $ 10.34 Million | xxxx | 9.9% |
| Rest of South America Urinary Incontinence Treatment Devices Market Sales Revenue | xxxx | $ 23.13 Million | xxxx | 8.7% |
| Middle East Urinary Incontinence Treatment Devices Market Sales Revenue | xxxx | $ 151.2 Million | $ 329 Million | 10.2% |
| Qatar Urinary Incontinence Treatment Devices Market Sales Revenue | xxxx | $ 12.1 Million | xxxx | 9.7% |
| Saudi Arabia Urinary Incontinence Treatment Devices Market Sales Revenue | xxxx | $ 53.22 Million | xxxx | 10.5% |
| Turkey Urinary Incontinence Treatment Devices Market Sales Revenue | xxxx | $ 12.1 Million | xxxx | 10.8% |
| UAE Urinary Incontinence Treatment Devices Market Sales Revenue | xxxx | $ 31.15 Million | xxxx | 10.7% |
| Egypt Urinary Incontinence Treatment Devices Market Sales Revenue | xxxx | $ 9.07 Million | xxxx | 10% |
| Rest of Middle East Urinary Incontinence Treatment Devices Market Sales Revenue | xxxx | $ 33.57 Million | xxxx | 9.4% |
| Africa Urinary Incontinence Treatment Devices Market Sales Revenue | xxxx | $ 83.16 Million | $ 168.2 Million | 9.2% |
| Nigeria Urinary Incontinence Treatment Devices Market Sales Revenue | xxxx | $ 6.65 Million | xxxx | 9.4% |
| South Africa Urinary Incontinence Treatment Devices Market Sales Revenue | xxxx | $ 29.27 Million | xxxx | 10.1% |
Urinary Incontinence Treatment Devices Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
The Urinary Incontinence Treatment Devices Market is a rapidly expanding segment within the global healthcare industry, driven by increasing prevalence rates of urinary incontinence (UI) and technological advancements in treatment options. Urinary incontinence, the involuntary leakage of urine, affects millions of individuals worldwide, with a higher incidence among the elderly, women, and individuals with chronic conditions like diabetes and obesity. The market includes various treatment devices aimed at alleviating the symptoms and improving the quality of life for those affected by this condition. Minimally invasive treatments, such as neuromodulation devices, catheters, and pelvic floor stimulators, are gaining popularity due to their effectiveness and reduced risk of complications. Innovations in wearable devices and non-invasive therapies are further enhancing patient comfort and accessibility, enabling more individuals to manage their condition at home.
In January 2024, Boston Scientific announced an agreement to acquire Axonics, Inc., a medical technology company specializing in the development and commercialization of sacral neuromodulation (SNM) devices for treating urinary and bowel dysfunction. This acquisition is anticipated to significantly enhance Boston Scientific's urology portfolio and contribute to the company's growth in the coming years. https://news.bostonscientific.com/2024-01-08-Boston-Scientific-Announces-Agreement-to-Acquire-Axonics,-Inc
Urinary incontinence is a prevalent health condition affecting millions of people worldwide, with the risk increasing as individuals age. According to the World Health Organization (WHO), the global geriatric population (aged 60 and above) is projected to double by 2050, driving a greater demand for treatment solutions. By 2030, one in six people globally will be 60 years or older, with the senior population rising from 1 billion in 2020 to 1.4 billion. By 2050, this number is expected to reach 2.1 billion, while the population of individuals aged 80 and older is forecasted to triple, reaching 426 million. Between 2015 and 2050, the proportion of people aged 60 and above will nearly double, increasing from 12% to 22%. Women, particularly those who have experienced childbirth and menopause, are at an increased risk of developing urinary incontinence due to weakened pelvic muscles and hormonal changes.
https://www.who.int/news-room/fact-sheets/detail/ageing-and-health/
Patients and healthcare providers are increasingly favoring minimally invasive treatments over traditional surgical procedures due to several advantages. These treatments, such as laser therapy and neuromodulation, carry a lower risk of complications, reducing the likelihood of infections and other issues. Additionally, they offer faster recovery times, which enhances patient compliance. Moreover, minimally invasive procedures often eliminate the need for extended hospital stays, leading to reduced healthcare costs.
Advanced urinary incontinence treatment devices, such as sacral nerve stimulation (SNS) implants, artificial urinary sphincters, and minimally invasive laser therapies, come with a high price tag, making them unaffordable for a large portion of the population. Surgical procedures like sling implantations or sphincter replacements involve additional costs, including hospitalization, surgeon fees, post-operative care, and follow-up treatments. Although some reimbursement policies exist, not all countries or insurance providers cover the full cost of treatment devices, making out-of-pocket expenses a barrier for many patients.
Artificial intelligence (AI) and machine learning (ML) algorithms are being integrated into urinary incontinence devices for real-time monitoring, automated data collection, and personalized treatment plans. Wearable incontinence sensors and biofeedback devices offer discreet, non-invasive solutions for monitoring bladder activity. Sacral Nerve Stimulation (SNS) and Tibial Nerve Stimulation (TNS) devices are minimally invasive alternatives to traditional surgeries, gaining popularity among patients and healthcare providers. Laser-based therapies for incontinence management are becoming more common, providing a non-surgical option for treatment. Innovations in self-catheterization techniques and portable incontinence management devices provide convenience for patients who prefer at-home treatment solutions.
Neuromodulation devices, like InterStim and Axonics Therapy, work by stimulating the nerves controlling bladder function, offering a safe and effective treatment for overactive bladder and urge incontinence. These devices are minimally invasive and provide long-term relief compared to traditional treatments, such as catheters, which require ongoing management. The growing trend of non-invasive wearable neuromodulation devices allows patients to manage their condition at home, improving convenience and compliance. The shift towards such therapies is also driven by increased patient comfort and reduced healthcare costs.
We have various report editions of Urinary Incontinence Treatment Devices Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
The competition is driven by the increasing demand for advanced, effective, and minimally invasive solutions to manage urinary incontinence, as well as the rising prevalence of the condition, particularly among the aging population. To maintain a competitive edge, companies are focusing on technological advancements in non-invasive treatments, such as wearable neuromodulation devices and minimally invasive therapies. The development of home-use devices that provide convenience and improve patient compliance is also a key area of focus.
In March 2022, Medtronic announced the first patient implants in the TITAN 2 pivotal study, which evaluates the implantable tibial neuromodulation (TNM) device for treating bladder incontinence. The TNM device is designed to provide continuous neuromodulation therapy, reducing the need for repeated clinic visits, thus easing the burden on both patients and physicians. This addition has expanded Medtronic's product portfolio in the urinary incontinence care segment. https://news.medtronic.com/2022-03-24-Medtronic-announces-first-patient-implants-of-investigational-implantable-tibial-neuromodulation-therapy-for-bladder-incontinence
Top Companies Market Share in Urinary Incontinence Treatment Devices Industry: (In no particular order of Rank)
| Companies | 2022 (A) | 2023 (A) | 2024 (A) | 2025 (A) |
|---|---|---|---|---|
| Becton Dickinson and Company | xxxx | xxxx | xxxx | xxxx |
| Boston Scientific Corporation | xxxx | xxxx | xxxx | xxxx |
| B Braun Melsungen AG | xxxx | xxxx | xxxx | xxxx |
| Caldera Medical Inc. | xxxx | xxxx | xxxx | xxxx |
| Coloplast A/S | xxxx | xxxx | xxxx | xxxx |
| ConvaTec Group plc | xxxx | xxxx | xxxx | xxxx |
| Hollister Incorporated | xxxx | xxxx | xxxx | xxxx |
| Medtronic plc | xxxx | xxxx | xxxx | xxxx |
| PROMEDON GmbH | xxxx | xxxx | xxxx | xxxx |
| Teleflex Incorporated | xxxx | xxxx | xxxx | xxxx |
| Zephyr Surgical Implants. | xxxx | xxxx | xxxx | xxxx |
*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive)
Request Any Company Profile for Preview Purpose OR Data Validation!
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
According to Cognitive Market Research, North America currently dominates the Urinary Incontinence Treatment Devices market, and the region is expected to have significant growth during the projected period. Women, especially those who have experienced childbirth, menopause, or other hormonal changes, are more likely to develop urinary incontinence. The population-based prevalence of UI stands at 45%, with the rate increasing with age—from 28% among women aged 30 to 39 to 55% among those aged 80 to 90. In North America, women account for a significant proportion of individuals with urinary incontinence, driving a greater demand for treatment solutions. Innovations in female-specific treatments, such as pelvic floor stimulators and sling procedures, have played a crucial role in advancing the market.
Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR). Chronic conditions such as diabetes, obesity, and neurological disorders are becoming more prevalent in the Asia Pacific region. India, for example, has the highest global prevalence of diabetes, with 212 million adults diagnosed in 2022, surpassing both China and the United States. A study published in The Lancet shows that the global diabetic population has quadrupled since 1990, now exceeding 800 million. These health issues contribute to the development of urinary incontinence, thereby increasing the demand for effective treatment solutions. In countries like China and India, the rising prevalence of diabetes is driving the need for more management devices for incontinence.
The current report Scope analyzes Urinary Incontinence Treatment Devices Market on 6 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
According to Cognitive Market Research, the global Urinary Incontinence Treatment Devices market size was estimated at USD 3780 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 1398.60 million in 2025 and will grow at a compound annual growth rate (CAGR) of 4.1% from 2025 to 2033.
According to Cognitive Market Research, the US had a major share in the Urinary Incontinence Treatment Devices market with a market size of USD 1103.50 million in 2025 and is projected to grow at a CAGR of 7.2% during the forecast period. In the US, the demand for the Urinary Incontinence Treatment Devices market is driven by increasing awareness about treatment options, and advancements in medical technology.
The Canadian Urinary Incontinence Treatment Devices market had a market share of USD 167.83 million in 2025 and is projected to grow at a CAGR of 8.2% during the forecast period. The country’s rising prevalence of urinary incontinence, government healthcare initiatives, and improved access to advanced treatment devices contribute to the growing demand.
The Mexico Urinary Incontinence Treatment Devices market is projected to witness growth at a CAGR of 7.9% during the forecast period, with a market size of USD 127.27 million in 2025..
According to Cognitive Market Research, the global Urinary Incontinence Treatment Devices market size was estimated at USD 3780 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 1096.20 million in 2025 and will grow at a compound annual growth rate (CAGR) of 7.9% from 2025 to 2033.
The United Kingdom Urinary Incontinence Treatment Devices market had a market share of USD 184.16 million in 2025 and is projected to grow at a CAGR of 8.7% during the forecast period. In the UK, Urinary Incontinence Treatment Devices sales witnessed an upswing due to the growing awareness campaigns encouraging early diagnosis and treatment of urinary incontinence.
The France Urinary Incontinence Treatment Devices market is projected to witness growth at a CAGR of 7.1% during the forecast period, with a market size of USD 100.85 million in 2025.
According to Cognitive Market Research, the German Urinary Incontinence Treatment Devices market size was valued at USD 217.05 million in 2025 and is projected to grow at a CAGR of 8.1% during the forecast period. In Germany, high healthcare expenditure, a well-established medical device industry, and the increasing adoption of advanced minimally invasive treatments, driving the market
The Italy Urinary Incontinence Treatment Devices market is projected to witness growth at a CAGR of 7.3% during the forecast period, with a market size of USD 94.27 million in 2025.
The Russia Urinary Incontinence Treatment Devices market is projected to witness growth at a CAGR of 6.9% during the forecast period, with a market size of USD 169.91 million in 2025
The Spain Urinary Incontinence Treatment Devices market is projected to witness growth at a CAGR of 7.0% during the forecast period with a market size of USD 89.89 million in 2025
The Sweden Urinary Incontinence Treatment Devices market is projected to witness growth at a CAGR of 8.0% during the forecast period, with a market size of USD 33.98 million in 2025.
The Denmark Urinary Incontinence Treatment Devices market is projected to witness growth at a CAGR of 7.7% during the forecast period, with a market size of USD 23.02 million in 2025
The Switzerland Urinary Incontinence Treatment Devices market is projected to witness growth at a CAGR of 7.6% during the forecast period, with a market size of USD 16.44 million in 2025.
The Luxembourg Urinary Incontinence Treatment Devices market is projected to witness growth at a CAGR of 8.2% during the forecast period, with a market size of USD 13.15 million in 2025.
The Rest of Europe's Urinary Incontinence Treatment Devices market is projected to witness growth at a CAGR of 6.6% during the forecast period, with a market size of USD 153.47 million in 2025.
According to Cognitive Market Research, the global Urinary Incontinence Treatment Devices market size was estimated at USD 3780 Million, out of which APAC held the market share of around 23% of the global revenue with a market size of USD 907.20 million in 2025 and will grow at a compound annual growth rate (CAGR) of 11.7% from 2025 to 2033.
According to Cognitive Market Research, the China Urinary Incontinence Treatment Devices market size was valued at USD 381.02 million in 2025 and is projected to grow at a CAGR of 11.2% during the forecast period. Urinary Incontinence Treatment Devices surged in China due to increasing number of healthcare facilities specializing in urological disorders.
The Japan Urinary Incontinence Treatment Devices market is projected to witness growth at a CAGR of 10.2% during the forecast period, with a market size of USD 125.19 million in 2025
The South Korea Urinary Incontinence Treatment Devices market had a market share of USD 108.86 million in 2025 and is projected to grow at a CAGR of 10.8% during the forecast period.
The Indian Urinary Incontinence Treatment Devices market is projected to witness growth at a CAGR of 13.6% during the forecast period, with a market size of USD 90.72 million in 2025. In India, the demand for the Urinary Incontinence Treatment Devices market is driven by the government initiatives to improve healthcare infrastructure, a surge in minimally invasive treatment preferences.
The Australian Urinary Incontinence Treatment Devices market is projected to witness growth at a CAGR of 11.0% during the forecast period, with a market size of USD 47.17 million in 2025.
The Singapore Urinary Incontinence Treatment Devices market is projected to witness growth at a CAGR of 12.0% during the forecast period, with a market size of USD 18.14 million in 2025.
The Taiwan Urinary Incontinence Treatment Devices market is projected to witness growth at a CAGR of 11.5% during the forecast period, with a market size of USD 35.38 million in 2025.
The South East Asia Urinary Incontinence Treatment Devices market is projected to witness growth at a CAGR of 12.5% during the forecast period, with a market size of USD 59.88 million in 2025.
The Rest of APAC Urinary Incontinence Treatment Devices market is projected to witness growth at a CAGR of 11.5% during the forecast period, with a market size of USD 40.82 million in 2025.
According to Cognitive Market Research, the global Urinary Incontinence Treatment Devices market size was estimated at USD 3780 Million, out of which South America held the market share of around 5% of the global revenue with a market size of USD 143.64 million in 2025 and will grow at a compound annual growth rate (CAGR) of 9.6% from 2025 to 2033.
According to Cognitive Market Research, the Brazil Urinary Incontinence Treatment Devices market size was valued at USD 61.48 million in 2025 and is projected to grow at a CAGR of 10.2% during the forecast period. Urinary Incontinence Treatment Devices flourished in Brazil due to country's rise in obesity and diabetes cases.
Argentina's Urinary Incontinence Treatment Devices market had a market share of USD 24.13 million in 2025 and is projected to grow at a CAGR of 10.5% during the forecast period. Argentina's growth of private healthcare facilities and ambulatory surgical centers (ASCs), driving the market.
Colombia Urinary Incontinence Treatment Devices market is projected to witness growth at a CAGR of 9.4% during the forecast period, with a market size of USD 12.78 million in 2025
Peru Urinary Incontinence Treatment Devices market is projected to witness growth at a CAGR of 9.8% during the forecast period, with a market size of USD 11.78 million in 2025.
Chile Urinary Incontinence Treatment Devices market is projected to witness growth at a CAGR of 9.9% during the forecast period, with a market size of USD 10.34 million in 2025
The Rest of South America's Urinary Incontinence Treatment Devices market is projected to witness growth at a CAGR of 8.7% during the forecast period, with a market size of USD 23.13 million in 2025.
According to Cognitive Market Research, the global Urinary Incontinence Treatment Devices market size was estimated at USD 3780 Million, out of which the Middle East held the major market share of around 2% of the global revenue with a market size of USD 151.20 million in 2025 and will grow at a compound annual growth rate (CAGR) of 10.2% from 2025 to 2033..
The Qatar Urinary Incontinence Treatment Devices market is projected to witness growth at a CAGR of 9.7% during the forecast period, with a market size of USD 12.10 million in 2025. Urinary Incontinence Treatment Devices sales flourish due to the country's increasing awareness of women's health issues and the growing availability of specialized urology treatments.
The Saudi Arabia Urinary Incontinence Treatment Devices market is projected to witness growth at a CAGR of 10.5% during the forecast period, with a market size of USD 53.22 million in 2025.
The Turkey Urinary Incontinence Treatment Devices market is projected to witness growth at a CAGR of 10.8% during the forecast period, with a market size of USD 12.10 million in 2025. Urinary Incontinence Treatment Devices sales flourished in Turkey due to country's growing role as a healthcare hub in the Middle East .
The UAE Urinary Incontinence Treatment Devices market is projected to witness growth at a CAGR of 10.7% during the forecast period, with a market size of USD 31.15 million in 2025.
The Egypt Urinary Incontinence Treatment Devices market is projected to witness growth at a CAGR of 10.0% during the forecast period, with a market size of USD 9.07 million in 2025.
The Rest of the Middle East Urinary Incontinence Treatment Devices market is projected to witness growth at a CAGR of 9.4% during the forecast period, with a market size of USD 33.57 million in 2025
According to Cognitive Market Research, the global Urinary Incontinence Treatment Devices market size was estimated at USD 3780 Million, out of which the Africa held the major market share of around 2% of the global revenue with a market size of USD 83.16 million in 2025 and will grow at a compound annual growth rate (CAGR) of 5.9% from 2025 to 2033.
The Nigeria Urinary Incontinence Treatment Devices market is projected to witness growth at a CAGR of 9.4% during the forecast period, with a market size of USD 6.65 million in 2025. Urinary Incontinence Treatment Devices sales flourish due to the advancements in medical technology and improved access to healthcare services.
The South Africa Urinary Incontinence Treatment Devices market is projected to witness growth at a CAGR of 10.1% during the forecast period, with a market size of USD 29.27 million in 2025.
The Rest of Africa Urinary Incontinence Treatment Devices market is projected to witness growth at a CAGR of 8.4% during the forecast period, with a market size of USD 47.23 million in 2025.
Conclusion
Research Analyst at Cognitive Market Research
LinkedIn | Profile | Book Appointment
Supriya Yadav is a skilled market researcher with strong expertise in the Medical Devices and Consumables industry. Known for her analytical precision and deep interest in healthcare innovation, she focuses on decoding key market trends, technological advancements, and evolving customer needs. Supriya excels at transforming complex industry data into meaningful insights that support strategic decision-making for healthcare stakeholders. Her commitment to understanding the future of medical technologies and improving patient-centric solutions makes her a valuable contributor in this rapidly advancing sector.
As a Research Analyst, I bring over two years of experience in market research, data analysis, and market estimation. I specialize in turning complex datasets into meaningful insights that help businesses identify opportunities, understand market dynamics, and make confident, growth-focused decisions.
My expertise spans across analyzing industry trends, forecasting market potential, mapping competitive landscapes, and studying consumer behavior to deliver actionable recommendations. With an MBA in Marketing and Finance, I combine strong analytical skills with strategic thinking, ensuring that every project I work on contributes real value to clients.
I am passionate about using research to uncover patterns, anticipate shifts, and deliver insights that drive measurable business impact. My goal is to continuously learn, innovate, and provide data-driven solutions that empower clients to succeed in a competitive environment.
Global Urinary Incontinence Treatment Devices Market Report 2025 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Urinary Incontinence Treatment Devices Industry growth. Urinary Incontinence Treatment Devices market has been segmented with the help of its Product Outlook:, Incontinence Type Outlook: End-user Outlook:, and others. Urinary Incontinence Treatment Devices market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
How are Segments Performing in the Global Urinary Incontinence Treatment Devices Market?
According to Cognitive Market Research, Urethral Slings is likely to dominate the Urinary Incontinence Treatment Devices Market. Urethral slings are widely recognized as one of the most effective treatments for stress urinary incontinence (SUI), a type of incontinence that occurs when physical activity or pressure on the bladder, such as coughing, sneezing, or laughing, causes urine leakage. Urethral slings work by supporting the urethra, preventing involuntary leakage of urine. Their high success rates and effectiveness in treating SUI have made them a preferred choice for many patients and healthcare providers, driving growth in this product segment.
Catheters is the fastest-growing segment in the Urinary Incontinence Treatment Devices Market. Chronic neurological conditions, such as multiple sclerosis, Parkinson’s disease, spinal cord injuries, and stroke, often lead to the loss of bladder control and the need for urinary catheters. As these disorders become more common, the demand for catheters, especially in long-term care settings, is increasing. For instance, stroke and spinal cord injury patients often require long-term catheterization, driving the demand for these devices.
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Urinary Incontinence Treatment Devices Industry. Request a Free Sample PDF!
According to Cognitive Market Research, the Stress Urinary Incontinence segment holds the largest share of the market. Stress urinary incontinence is one of the most common forms of urinary incontinence, particularly among women. It occurs when physical activities such as coughing, sneezing, laughing, or exercise increase pressure on the bladder, leading to involuntary urine leakage. As women age, especially post-pregnancy or during and after menopause, the prevalence of SUI increases. According to studies, approximately 50-60% of women experience some form of SUI during their lifetime, making it a significant portion of the urinary incontinence population. The growing population of elderly women and those who have experienced childbirth increases the demand for treatments specific to this type of incontinence.
In the Urinary Incontinence Treatment Devices Market, the Urge Urinary Incontinence segment has been expanding at a rapid pace. Urge urinary incontinence is often associated with overactive bladder (OAB), a condition characterized by the frequent urge to urinate, with or without incontinence. OAB is becoming more common, particularly as the global population ages. A study published in the journal BJU International estimated that around 16% of adults worldwide experience OAB symptoms. As the prevalence of OAB rises, there is a growing need for devices and treatments that can help manage the condition, driving market growth for UUI treatment devices. The association between OAB and UUI ensures that a large number of patients require treatment options for managing their symptoms, including devices that can control bladder urgency.
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
According to Cognitive Market Research, The Hospitals segment holds the largest market share. While many individuals with UI can manage their condition with less invasive treatments such as pelvic floor exercises or medications, more severe cases require advanced interventions that are typically only available in hospitals. Treatments such as surgical procedures, sacral neuromodulation implants, and botulinum toxin injections require professional healthcare teams, specialized equipment, and post-procedure monitoring, all of which are typically provided in a hospital setting. As the number of patients with severe or complicated UI cases increases, hospitals are seeing a greater demand for advanced treatment devices, which drives growth in this segment.
In the Urinary Incontinence Treatment Devices market, the rapidly growing sector is the Ambulatory Surgery Centers category. ASCs are increasingly becoming the preferred setting for minimally invasive surgeries, which are commonly used for treating urinary incontinence. Many urinary incontinence treatments, such as sacral neuromodulation, botulinum toxin injections, and slings and implants, can be performed with minimal incision, reduced recovery time, and lower risks compared to traditional surgeries. The ability to perform these procedures efficiently and effectively in an ASC setting has led to a growing demand for treatment devices tailored to these interventions, driving the growth of the ASC segment.
Disclaimer:
| Product Outlook: | Urethral Slings, Electrical Stimulation Devices, Artificial Urinary Sphincters, Catheters |
| Incontinence Type Outlook: | Stress Urinary Incontinence, Urge Urinary Incontinence, Mixed Incontinence, Overflow Incontinence |
| End-user Outlook: | Hospitals, Ambulatory Surgery Centers, Clinics, Home Use |
| List of Competitors | Becton Dickinson and Company, Boston Scientific Corporation, B Braun Melsungen AG, Caldera Medical Inc., Coloplast A/S, ConvaTec Group plc, Hollister Incorporated, Medtronic plc, PROMEDON GmbH, Teleflex Incorporated, Zephyr Surgical Implants. |
Chapter 1 2026 Geopolitical Outlook - Urinary Incontinence Treatment Devices Market Detailed Analysis
This chapter isn't just about technology; it’s about certainty. We show you how AI is being used in leading industries so you can apply those same 'High-Speed' and 'High-Accuracy' principles to your own market strategy
Chapter 2 AI's Impact on Market - Detailed Qualitative Analysis
This chapter will help you gain GLOBAL Market Analysis of Urinary Incontinence Treatment Devices. Further deep in this chapter, you will be able to review Global Urinary Incontinence Treatment Devices Market Split by various segments and Geographical Split.
Chapter 3 Global Market Analysis
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
This chapter will help you gain North America Market Analysis of Urinary Incontinence Treatment Devices. Further deep in this chapter, you will be able to review North America Urinary Incontinence Treatment Devices Market Split by various segments and Country Split.
Chapter 4 North America Market Analysis
This chapter will help you gain Europe Market Analysis of Urinary Incontinence Treatment Devices. Further deep in this chapter, you will be able to review Europe Urinary Incontinence Treatment Devices Market Split by various segments and Country Split.
Chapter 5 Europe Market Analysis
This chapter will help you gain Asia Pacific Market Analysis of Urinary Incontinence Treatment Devices. Further deep in this chapter, you will be able to review Asia Pacific Urinary Incontinence Treatment Devices Market Split by various segments and Country Split.
Chapter 6 Asia Pacific Market Analysis
This chapter will help you gain South America Market Analysis of Urinary Incontinence Treatment Devices. Further deep in this chapter, you will be able to review South America Urinary Incontinence Treatment Devices Market Split by various segments and Country Split.
Chapter 7 South America Market Analysis
This chapter will help you gain Middle East Market Analysis of Urinary Incontinence Treatment Devices. Further deep in this chapter, you will be able to review Middle East Urinary Incontinence Treatment Devices Market Split by various segments and Country Split.
Chapter 8 Middle East Market Analysis
This chapter will help you gain Middle East Market Analysis of Urinary Incontinence Treatment Devices. Further deep in this chapter, you will be able to review Middle East Urinary Incontinence Treatment Devices Market Split by various segments and Country Split.
Chapter 9 Africa Market Analysis
This chapter provides an in-depth analysis of the market share among key competitors of Urinary Incontinence Treatment Devices. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 10 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 11 Qualitative Analysis (Subject to Data Availability)
Segmentation Product Outlook: Analysis 2019 -2031, will provide market size split by Product Outlook:. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by Product Outlook: Analysis 2022 - 2034
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 13 Market Split by Incontinence Type Outlook: Analysis 2022 - 2034
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 14 Market Split by End-user Outlook: Analysis 2022 - 2034
Chapter 15 Urinary Incontinence Treatment Devices Price Trend Analysis
Chapter 16 Urinary Incontinence Treatment Devices Import/Export Analysis
Chapter 17 Urinary Incontinence Treatment Devices Production Analysis
Chapter 18 Gap Analysis
Chapter 19 Strategy Analysis
Chapter 20 Profitability and Gross Margin Analysis
Chapter 21 TAM Analysis
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Urinary Incontinence Treatment Devices market
Chapter 22 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Chapter 23 Research Methodology and Sources
1 Data Gathering
2 Data Validation
3 Data Presentation
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for our full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants your team direct access to our lead analysts for bespoke strategic consultation.